Kornitzer Capital Management Inc. KS trimmed its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 2.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 212,967 shares of the company's stock after selling 4,554 shares during the quarter. Kornitzer Capital Management Inc. KS owned 0.17% of Clorox worth $34,588,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Brooklyn Investment Group lifted its stake in shares of Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company's stock valued at $25,000 after purchasing an additional 95 shares during the last quarter. Prospera Private Wealth LLC purchased a new stake in Clorox during the 3rd quarter valued at $27,000. Continuum Advisory LLC lifted its position in Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company's stock worth $30,000 after buying an additional 138 shares during the last quarter. Asset Planning Inc purchased a new position in Clorox during the fourth quarter worth $32,000. Finally, Carolina Wealth Advisors LLC bought a new position in Clorox during the third quarter valued at $48,000. Institutional investors own 78.53% of the company's stock.
Clorox Stock Up 2.8 %
Shares of Clorox stock traded up $4.34 during trading on Friday, hitting $157.41. 2,375,494 shares of the stock traded hands, compared to its average volume of 1,353,779. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The stock's fifty day simple moving average is $157.87 and its 200 day simple moving average is $159.63. The firm has a market cap of $19.39 billion, a P/E ratio of 43.01, a price-to-earnings-growth ratio of 2.58 and a beta of 0.42. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52.
Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period last year, the company posted $2.16 earnings per share. On average, equities analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.
Analyst Ratings Changes
Several equities research analysts have recently issued reports on the stock. Royal Bank of Canada restated a "sector perform" rating and issued a $150.00 target price on shares of Clorox in a report on Thursday, January 30th. Evercore ISI raised their price objective on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Barclays upped their target price on Clorox from $130.00 to $140.00 and gave the company an "underweight" rating in a research note on Wednesday, February 5th. JPMorgan Chase & Co. increased their price target on Clorox from $171.00 to $173.00 and gave the stock a "neutral" rating in a report on Tuesday, February 4th. Finally, StockNews.com cut Clorox from a "buy" rating to a "hold" rating in a report on Sunday, January 5th. Four equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat.com, Clorox has an average rating of "Hold" and a consensus price target of $158.21.
Check Out Our Latest Stock Report on CLX
About Clorox
(
Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
See Also

Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.